Appendix: Post-Investment Governance & Board Dynamics

The board seat is the visible change. The invisible one matters more: the moment outside shareholders exist, the founder (now a director and officer of the corporation) takes on fiduciary duties. A fiduciary duty is a legal obligation to act in someone else's financial interest ahead of your own. Under Delaware law, which governs most venture-backed companies, directors owe two:

• The duty of care: being informed and deliberate, gathering the relevant facts, taking the time a prudent person would, and deciding with reasonable diligence rather than carelessly.
• The duty of loyalty: putting the corporation's interest ahead of your own, and disclosing and standing aside from conflicts of interest rather than exploiting your position.

Owed to Whom

Here is the part founders misread. These duties are owed to the corporation and its shareholders as a whole, not to the founder, not to the largest holder, and not to any single class. The founder-CEO who still thinks of it as "my company" is now legally answerable to every name on the cap table: co-founders, employees who hold options and vested common, angels, and the new preferred investors alike. Deciding purely for your own benefit at the expense of the other shareholders is not merely bad form; it is a breach.

Directors get real protection when they act properly. The business judgment rule presumes that an informed, disinterested, good-faith decision was sound, and courts will not second-guess it even if it turns out badly. But the protection is conditional: it evaporates when a director is conflicted or uninformed. That is why a founder who is also a director should recuse from votes where their personal interest and the shareholders' interest diverge: approving a loan to themselves, setting their own compensation, or voting on a transaction that pays their share class differently from the others.

Where the Conflict Bites

The sharpest tension appears at exit, and it is worth flagging now because Part Five builds on it. Preferred investors and common shareholders can want different outcomes from the same sale; the Week 6 waterfall is exactly why. An acquisition that clears the preference stack but leaves little for common can be great for the fund and worthless for the founders and employees. A director sitting in both chairs (a founder who is also a large preferred holder, or an investor-director voting on a deal that returns their fund) faces a genuine conflict, and the duty of loyalty is what the law uses to police it.

Week 8 framed the four costs of raising equity as cost, dilution, control, and signaling. Governance is where the control cost stops being an abstraction and becomes a standing feature of how the company runs. It is not a penalty a hostile investor imposes; it is the structural price of selling ownership to people who cannot run the company day to day and therefore need a mechanism to protect the capital they put in.

Founder-Controlled vs. Board-Governed

The two regimes differ on a single axis: who has the final say on the decisions that determine the company's fate.

The right-hand column is not the whole of the Week 6 control kit. Board composition is the visible layer; underneath sit the protective provisions, contractual veto rights that let the preferred block specified actions regardless of the board vote. These commonly require preferred approval to sell the company, issue new stock senior to theirs, change the charter, or increase the option pool. Governance therefore operates at two levels at once: the board decides what happens, and the protective provisions let the investors stop a defined list of things from happening even if the board is willing.

Why a Rational Founder Says Yes

This connects straight back to Week 1's Rich-versus-King choice. A founder who wants to stay king can keep the company founder-controlled, but only by not taking priced institutional money, which usually means staying small. Choosing to be rich, in Wasserman's framing, means accepting dilution and governance as the entry fee for capital that can build something large. The trade is real and it is a choice, not a trap: the founder gives up unilateral control in exchange for money, a board that (at its best) improves decisions, and investors whose returns now depend on the company's success. Governance is the mechanism that makes those investors willing to hand over the capital at all.

Boards grow in a predictable rhythm. Each priced round typically adds a preferred seat for the new lead, and to keep the board balanced the parties often add an independent at the same time. The result is a seat count that climbs from two to three to five to seven as the company raises, with the founders' share of the board falling at every step even when the founders add no partners of their own.

A representative seat-evolution path

Read the last two columns together and the shift is unmistakable. At formation and seed the founders are the board, so any decision they agree on carries. The seed investor takes a seat but cannot outvote two founders. The turn happens at Series A. The lead adds a second preferred seat and the parties seat a mutually approved independent, and the board becomes 2 common, 2 preferred, 1 independent. Now no bloc holds a majority on its own. The two founders cannot pass a contested measure over the objection of both investors and the independent, and the investors cannot pass one over the objection of the founders and the independent. The independent director becomes the decisive vote, which is exactly why both sides insist on approving the person.

Founder-majority, balanced, investor-influenced

Practitioners describe the same path in three phases. A founder-majority board (formation and seed here) is one where the common seats alone are more than half the total. A balanced board (the classic 2-2-1 at Series A) has no controlling bloc and turns on the independent. An investor-influenced board emerges when the preferred seats plus the independents they can persuade reach a majority, as the Series B row shows: three preferred seats and two independents can assemble four of seven votes without a single founder. Nothing here requires a hostile investor or a broken company; this is the ordinary arithmetic of raising money from people who insist on a seat for their capital.

The specific numbers are conventions, not rules. Many Series A boards stay at five seats through Series B rather than expanding to seven; some keep a 3-2 founder-leaning structure when the founders have leverage of the kind Week 9 described; a hot round can leave founders a majority far longer, and a down round or a struggling company can compress founder representation faster. The path above is the median case, the one to plan against, not a prophecy.

Economic ownership is what the cap table measures: the percentage of the company's value a shareholder is entitled to in a sale or a distribution. It dilutes mechanically, round by round, exactly as Week 6 showed: every new issuance shrinks each existing holder's slice, and the dilution compounds. Board control is a separate quantity entirely. It is set by the voting agreement and the charter, which specify how many seats each class elects, and it changes only when those documents are renegotiated, typically at a financing, when the new lead demands a seat.

Why a founder can own a majority and not control the board

Return to the Series A row. Suppose the founding team together still owns roughly 55% of the company's shares after the round, an economic majority, yet holds only 2 of the 5 board seats. Every ordinary board decision now requires a vote the founders cannot win alone, even though they own more of the company than everyone else combined. Their 55% controls the outcome of a shareholder vote and their share of the proceeds in a sale, but it does not elect a third director. Seat math, not share percentage, governs the boardroom.

The reverse happens too. A founder can fall well below 50% economic ownership, diluted to 30% or less by later rounds, and still control the board, if the voting agreement continues to let the common holders elect a majority of the seats. Google and Meta are the famous public versions of this, using dual-class stock so that founders who own a minority of the economics still command a majority of the votes; the private-company version is simply a board structure that keeps founder-elected seats in the majority. The lesson is that the percentage on the cap table and the number of seats in the boardroom are set by different instruments and can point in opposite directions.

What to negotiate, and when

Because control is written into the voting agreement, it is negotiated at the term-sheet stage alongside the economics of Week 6, not discovered afterward. The founder's leverage over board structure is highest before signing and erodes with each subsequent round, so the seat that matters most is often the independent: keeping the Series A board at 2-2-1 rather than conceding a second preferred seat, and retaining founder approval over who the independent is, preserves the balance far longer than fighting over a fraction of a percent of ownership would. This is the control cost from Week 8 made specific: the price of capital is paid partly in dilution and partly in seats, and the two are traded at the same table.

An investor who cannot run the company still needs to see it. Two overlapping mechanisms give that visibility, and they are frequently confused because both produce documents. They are not the same, and the difference is which one survives when the contract is silent.

Information rights are contractual. They are granted in the Week 6 package (usually in the investor rights agreement, not the charter) and they entitle the holder to a defined stream of reporting: typically annual audited or reviewed financials, quarterly unaudited statements, an annual operating budget approved by the board, and an up-to-date capitalization table on request. These rights are almost always reserved for major investors (holders above a negotiated share threshold), so the cap table's long tail of small holders does not each receive a quarterly financial package. Information rights are a creature of the deal: they exist because the term sheet says so, they run to whoever meets the threshold, and they commonly terminate at an IPO, when public reporting supersedes them.

Inspection rights are statutory. Under the corporate law of the state of incorporation (for the Delaware C-corp that most venture-backed startups are, this is Section 220 of the General Corporation Law), a shareholder has a baseline legal right to inspect the company's books and records for a proper purpose, meaning a purpose reasonably related to their interest as a shareholder. This right exists whether or not a contract grants it, and it cannot be fully bargained away. But it is narrower and more adversarial than contractual reporting: the holder must state a proper purpose, the company can contest it, and exercising the right often signals a dispute rather than routine oversight.

Why Both Exist

The two form a floor and a superstructure. Inspection rights are the floor every shareholder stands on; information rights are the richer, negotiated layer a major investor builds on top. A founder who withholds financials from a major investor is not just breaching the investor rights agreement; the investor also retains the statutory backstop to demand records through a more hostile channel. In practice, healthy companies rarely reach the statute: reporting flows automatically because well-run boards want informed investors, and the monthly or quarterly board deck from Part Four does most of the work. The statutory right matters precisely when things are going badly and the contractual stream has dried up.

By this point three separate approval mechanisms are in play, and clear governance depends on not confusing them. A given decision may need to clear one layer, two, or all three, and each answers to a different body under a different document.

The layers are cumulative, not alternatives, and a single action can trip all three at once. Selling the company is the clearest case. The transaction must be approved by the board (it is a fundamental corporate act); then by the shareholders under the statute (typically a majority of the outstanding stock on an as-converted basis, sometimes with the preferred voting as its own class as well); and then, separately, it must satisfy the protective provision that lists a sale among the actions requiring preferred class consent. Three locks on one door. This is why the minority veto in Knowledge Check 5 works: the seed investor did not need to control the board or the shareholder majority. Clearing the protective-provision layer alone was enough to stop the deal, because all three locks must open.

The Drag-Along: The Mirror Image

Stacked approvals create a holdout problem in the other direction. A sale that has cleared the board, the shareholder majority, and the preferred class can still be sabotaged by a single small holder who refuses to sign the deal documents, tender their shares, or waive appraisal rights, extracting a payment for their cooperation or simply blocking the close. The drag-along is the counterweight. It is a provision in the Week 6 voting agreement under which, once a defined threshold approves a sale (commonly the board, a majority of the preferred, and a majority of the common all together), every remaining shareholder is contractually bound to vote for the transaction and sell on the same terms. The approving group "drags" the rest along.

Read protective provisions and the drag-along as a matched pair. The protective provision lets the preferred block a sale the majority wants; the drag-along lets an approving majority compel a sale the minority resists. Together they route the decision to a defined coalition and deny a veto to everyone outside it, which is also what forces every holder into the Week 6 liquidation waterfall on the agreed terms, whether they like the price or not.

Pre-wiring resolves disagreement efficiently; it does not exist to eliminate it. The instinct of an anxious first-time CEO is to keep the board comfortable: to smooth the deck, downplay the risks, and treat any pushback as a threat to be neutralized. The more useful mental model is the reverse: a board that rarely disagrees with the CEO is not a sign of a great CEO; it is a sign of a useless board. The directors were added to the cap table, at real cost in equity and control (the Week 8 trade-offs), precisely because they see things the CEO does not. A boardroom where dissent is unwelcome quietly converts an expensive asset into a passive one.

So the discipline is to run toward disagreement rather than around it. When a director is skeptical, the move is to draw the objection out fully, state it back in its strongest form, and engage it rather than deflect it or wait for the meeting to move on. This is uncomfortable, and it is the entire point: the disagreement the CEO suppresses in the boardroom is the risk the company discovers later in the market. A board that argues well in the room is doing exactly the job the founder recruited it for.

The board as resource, not just oversight

Directors do two different jobs, and founders who conflate them get less from their boards. The first is oversight, the fiduciary and monitoring role: approving budgets and option grants, overseeing the audit and the CEO, exercising the protective provisions from Part Three. This is the role the legal documents describe, and it is real. But the second job is where a good early board earns its keep: it is a resource. A venture director sits on a portfolio of companies and has watched the same problems play out many times; that pattern-recognition, plus a rolodex the founder does not have, is worth more day-to-day than the oversight function. Recruiting a VP of Engineering, opening a door to an enterprise customer, sanity-checking a term sheet, offering judgment on a decision they have seen ten times before: this is the help a CEO should be extracting constantly, and most of it happens between meetings, not in them.

Understanding the resource role also means understanding its limits, which trace back to the fund model. A venture director's time is rationed across a whole portfolio, and the Week 7 economics (reserves, the carry clock, the fund's own return math) shape which companies get the most attention and what advice they hear. The Week 1 Rich-versus-King tension surfaces here too: the same director who is an invaluable resource on Tuesday is the person who can vote to replace the CEO on Wednesday. Both roles live in the same seat, and the founder who forgets the second while enjoying the first is the one caught off guard.

Observers and the executive session

Two structural features shape who is in the room. The first is the board observer: a person (often from a smaller investor, or a larger fund that wants presence without a formal seat) who attends meetings and receives materials but holds no vote and owes no fiduciary duty. Observers add expertise and eyes without expanding the voting body, which is why founders often prefer granting an observer seat to granting a director seat. But observer rights are not free: each additional body in the room makes candor harder and the meeting larger, and observer seats accumulate quietly across rounds until the meeting has more spectators than decision-makers. Cap the number, and put a clean removal right in the documents.

The second is the executive session: a portion of the meeting, usually at the end, where a defined subset stays and the rest step out. Most commonly the CEO leaves and the non-management directors meet alone; sometimes the independent and investor directors meet without any management present. A first-time founder can read this as a vote of no confidence, the board conspiring in the CEO's absence. It is the opposite: the executive session is routine, healthy governance. It gives directors a protected space to discuss the things they cannot comfortably raise with management in the room, principally CEO performance and compensation, and a board that never holds one is failing at oversight, not protecting the CEO. The mature move is for the CEO to institute the executive session themselves, as a standing item, and to ask for the feedback that comes out of it.

Founder succession exposes a deeper question about whose interests the board is actually bound to serve. Directors of a Delaware corporation owe their fiduciary duties, care and loyalty, to the corporation and its common stockholders. By definition, they do not owe those duties to the preferred stockholders as such. Preferred stock is, at bottom, a contract: its rights to a liquidation preference, to antidilution, and to protective provisions live in the certificate of incorporation and are enforced as contract rights rather than as fiduciary entitlements. When the interests of preferred and common point the same direction, as when a company grows into a large, clean exit, the distinction is largely invisible. When they split, it decides cases.

The split creates a specific hazard, because most venture directors are dual fiduciaries. An investor's designated director sits on the board owing fiduciary duties to the common, while simultaneously being a partner or employee of the fund that holds the preferred and that appointed her. In an ordinary up-and-to-the-right outcome those hats align. In a sale that clears the preference stack but leaves common with little or nothing, they collide: the transaction that maximizes the fund's return can be the transaction that zeroes the stockholders to whom the director owes her duty.

In re Trados

The reference case is In re Trados Incorporated Shareholder Litigation, 73 A.3d 17 (Del. Ch. 2013), which the ef-10 appendix flagged from the financing side and which we can now read as a governance case. Trados was sold for roughly $60 million. The preferred stockholders' liquidation preferences, together with a management incentive plan carved out for the executives who negotiated and stayed through the deal, absorbed essentially all of the proceeds. The common stockholders received nothing. Common holders sued, arguing the venture-appointed directors had steered the company into a sale that served the preferred's need for liquidity rather than any prospect of value for common.

The Delaware Court of Chancery held that the directors owed their duties to the common, not to the preferred whose funds had appointed them, and, because a majority of the board was conflicted, reviewed the sale under the demanding entire fairness standard, which asks whether the transaction was fair in both process and price rather than deferring to the board's business judgment. The board escaped liability, but only on a narrow and unflattering ground: the court found, after a full trial, that the common stock had no economic value even if the company had stayed independent, so the sale that paid common nothing had not in fact deprived common of anything it was owed. The directors were vindicated on the numbers, not on their process, which the court criticized for never seriously considering common's interest.

What the case tells a board to do

The operative lesson is procedural, and it applies to any board approving a conflicted, preference-heavy transaction, whether a sale, a recap, or a preference-clearing bridge:

• Name the conflict. Recognize when the board is a dual-fiduciary board and when preferred and common interests have diverged. The failure the court punished was not a bad price; it was a board that behaved as if it had no obligation to common at all.
• Actually weigh the effect on common. Consider and document the alternatives to the conflicted deal, such as remaining independent, finding a different buyer, or using a different structure, and what each does for the common stockholders specifically.
• Cleanse the process. Where possible, route the decision through mechanisms that neutralize the conflict: a special committee of independent, disinterested directors, or an informed vote of the common (or of the disinterested minority). Proper cleansing can restore business-judgment deference and shift the burden back to the plaintiffs.

The Trados split, with preferred and common pulling apart while dual fiduciaries sit on both sides, is not a courtroom curiosity. It is the ordinary condition of a company in distress, and distress is exactly where the board's hardest decisions cluster. The ef-10 appendix priced the instruments of adversity: the insider bridge, the priced down round, pay-to-play, and the recap. Here we govern them.

The conflicted insider round

When a struggling company's only realistic source of capital is the investors already on its cap table (ef-10's insider bridge), the financing is a related-party transaction. The insiders setting the price, the discount, the cap, and any seniority premium are the same parties buying the paper, and they usually sit on the board that approves it. Every term that shifts value toward the new money, whether a low cap, a 2x conversion premium, or a senior preference, shifts it away from common and from non-participating insiders. The governance response mirrors Trados: the interested directors should not set their own terms unchecked. Best practice is a disinterested or independent process, typically a special committee, a market check where feasible, and an offer of pro rata participation rights to existing holders so the round is not quietly priced for the lead's benefit, together with a documented record of why the terms are fair to the company and its common.

Down rounds, recaps, and the duty that survives them

A down round dilutes; a recapitalization can wash prior holders out to a residual stake (ef-10). Both are permissible, and sometimes both are the only alternative to insolvency. But both are precisely the transactions where a conflicted board can dress a transfer from common to preferred as a rescue. The clean-versus-dirty logic from the negotiation appendix has a governance corollary: a board that accepts a flat headline valuation loaded with a 2x senior preference and a full ratchet, when an honestly lower clean price was available, has favored the optics that protect the preferred's mark over the structure that would have left more for common. That is the kind of choice a plaintiff, and a court applying entire fairness, will later scrutinize.

Insolvency does not flip the duty

A persistent myth holds that once a company is insolvent, directors' duties shift to its creditors. Delaware law is narrower than that. Even at actual insolvency, directors continue to owe their duties to the corporation and its common stockholders; what changes is that once the company is actually insolvent, creditors gain standing to bring a derivative claim on the corporation's behalf. Merely entering the "zone of insolvency" does not by itself confer that standing or create any direct duty to creditors (North American Catholic Ed. Programming Found. v. Gheewalla, Del. 2007). The board's job does not become maximizing the preferred's recovery or the creditors' recovery. It remains stewarding the enterprise for its residual owners, which is why the Trados discipline, namely name the conflict, weigh the effect on common, and cleanse the process, runs through distress decisions generally rather than standing as an exception to them.

Two conditions turn the aligned board of the growth years into a conflicted one: an exit near the preference stack, and a fund running out of time. Take them in turn, then together, because the damage is worst when they arrive at once.

The preference wedge, computed

Suppose investors put in $50M of preferred with a standard 1x non-participating preference, and after all rounds the preferred owns 50% of the company on an as-converted, fully diluted basis; common owns the other 50%. Now price three exits through the Week 6 waterfall.

Read the middle band closely. Between a $50M and a $100M exit, the preferred is capped at its $50M preference and takes not one dollar more as the price rises. Every incremental dollar in that band flows entirely to common. Above $100M, incremental dollars split 50/50. So at a $60M sale, common has enormous leverage to gain from pushing the outcome higher, while the preferred is flat all the way up to $100M. The two sides now want different things: common wants patience and a bigger number; the preferred, already whole at $50M, wants certainty.

Conversion crossover. Preferred converts when its as-converted share exceeds its preference: ownership × exit value > preference. Here 0.50 × exit > $50M, so the crossover is a $100M exit. Below it, common captures the marginal dollar; above it, everyone shares pro rata.

The fund clock, pushing the same way

Now add Week 7. The investor is a GP deploying a ten-year fund. It earns carry only on realized gains, it must eventually return capital to its LPs, and it is likely raising its next fund on the strength of its distributions-to-paid-in (DPI). Suppose this position is at year eight of the fund's life, the reserves earmarked to support it are spent, and there is no dry powder left to join another round. Offered a $60M sale that returns the $50M preference now, versus a possible $200M in four more years or a possible zero, the GP's own incentives (the clock, visible DPI for the next fundraise, no reserves to defend the position through a dilutive round) can favor selling now even when holding is plainly better for common. The founders and employees, whose claim is the residual and who capture the entire marginal dollar below the crossover, want to wait. The board sits exactly on this wedge.

The fiduciary line, and why it is thin

Delaware law is clear in principle: directors owe their duties to the common stockholders and the corporation as a whole, not to the class that elected them. A director placed on the board by the preferred cannot simply steer the company toward whatever delivers the preferred its preference and an exit. The governing case is In re Trados, 73 A.3d 17 (Del. Ch. 2013), where preferred-appointed directors approved a sale in which the common received nothing while the preferred took its preference plus a management carve-out. The court held the process was not entirely fair (the directors had not consciously sought to maximize value for the common), yet awarded no damages, because on the facts the common stock was worth zero anyway. That is the honest lesson twice over: the legal duty runs to common, but the conflict is structural and hard to police, and even a flawed process can survive when common had little to lose. Governance narrows the room for this; it does not close it.

Because the conflict moments arrive years after the terms are set, the defenses have to be chosen at the deal, when everyone is aligned and no one is fighting. Three levers matter most, and each is negotiated once to be used much later.

Choose the people, then the structure

• The directors themselves. Over a seven-year hold, judgment and the ability to disagree without rupturing the relationship outweigh any single term. A director who will tell a founder an uncomfortable truth in year three, and back the company against their own fund's short-term convenience in year eight, is the asset. Diligence a prospective investor's directors the way they diligence you: talk to founders they backed through a hard exit, not just a good one.
• The independent seat. The board configurations from Part Two turn on who holds the swing vote when founder-elected and preferred-elected directors split. How the independent is chosen (mutual consent of both sides versus effective appointment by the preferred) is more consequential than the raw seat count, because that is the seat that decides the modest-exit vote. Negotiate the selection mechanism, not just the number.
• The terms that bite at exit. Protective-provision scope, the drag-along threshold that can force common to sell, and any redemption or time-based sale rights all lie quiet during the growth years and activate exactly when interests diverge. Price them for the moment they matter, not for the friendly boardroom in which they are signed (Week 8's control lens).

The honest limits

Here is where the entire module has to be candid about itself. Governance frameworks assume good-faith actors and reasonably clean incentives. When those hold, the board seats, fiduciary duties, and consent rights this course has described do real work: they force process, surface conflicts, and give a wronged founder or common holder standing to object. But the frameworks are probabilistic, not protective. A determined majority acting within the documents can still cause outcomes that harm founders and common. A voting agreement is enforceable; a drag-along executes; a board majority controls the company. Fiduciary duty is real, but it is slow, expensive, and hard to win: recall that In re Trados found a flawed process and still awarded nothing. Governance raises the cost and lowers the probability of bad-faith behavior. It does not make founders safe, and any part of this module that implied otherwise would be lying to you.

Closing the loop

That returns the course to where Week 1 began. Wasserman's Rich-versus-King tension is not resolved at founding; it is re-litigated at every board meeting and decided, finally, at the exit, when control and proceeds are allocated under rules written years earlier. Founder-CEO succession (Part Five) is one expression of it; the modest-exit conflict is another. The through-line of this appendix is that governance is the machinery that divides control and money when interests diverge, and the time to understand that machinery is while the pie is still growing and no one has any reason to fight, not in the week the acquisition offer lands.